These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 9242521)

  • 21. alpha-fetoprotein causes apoptosis in tumor cells via a pathway independent of CD95, TNFR1 and TNFR2 through activation of caspase-3-like proteases.
    Dudich E; Semenkova L; Dudich I; Gorbatova E; Tochtamisheva N; Tatulov E; Nikolaeva M; Sukhikh G
    Eur J Biochem; 1999 Dec; 266(3):750-61. PubMed ID: 10583368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Camptothecin-induced apoptosis in p53-null human leukemia HL60 cells and their isolated nuclei: effects of the protease inhibitors Z-VAD-fmk and dichloroisocoumarin suggest an involvement of both caspases and serine proteases.
    Shimizu T; Pommier Y
    Leukemia; 1997 Aug; 11(8):1238-44. PubMed ID: 9264376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Affinity labeling displays the stepwise activation of ICE-related proteases by Fas, staurosporine, and CrmA-sensitive caspase-8.
    Takahashi A; Hirata H; Yonehara S; Imai Y; Lee KK; Moyer RW; Turner PC; Mesner PW; Okazaki T; Sawai H; Kishi S; Yamamoto K; Okuma M; Sasada M
    Oncogene; 1997 Jun; 14(23):2741-52. PubMed ID: 9190889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug resistance towards etoposide and cisplatin in human melanoma cells is associated with drug-dependent apoptosis deficiency.
    Helmbach H; Kern MA; Rossmann E; Renz K; Kissel C; Gschwendt B; Schadendorf D
    J Invest Dermatol; 2002 Jun; 118(6):923-32. PubMed ID: 12060385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticancer drugs induce caspase-8/FLICE activation and apoptosis in the absence of CD95 receptor/ligand interaction.
    Wesselborg S; Engels IH; Rossmann E; Los M; Schulze-Osthoff K
    Blood; 1999 May; 93(9):3053-63. PubMed ID: 10216102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effector caspases are dispensable for the early nuclear morphological changes during chemical-induced apoptosis.
    Johnson VL; Ko SC; Holmstrom TH; Eriksson JE; Chow SC
    J Cell Sci; 2000 Sep; 113 ( Pt 17)():2941-53. PubMed ID: 10934034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequential activation of three distinct ICE-like activities in Fas-ligated Jurkat cells.
    Greidinger EL; Miller DK; Yamin TT; Casciola-Rosen L; Rosen A
    FEBS Lett; 1996 Jul; 390(3):299-303. PubMed ID: 8706881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis.
    Tolomeo M; Dusonchet L; Meli M; Grimaudo S; D'Alessandro N; Papoff G; Ruberti G; Rausa L
    Cell Death Differ; 1998 Sep; 5(9):735-42. PubMed ID: 10200532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-induced apoptosis in lung cnacer cells is not mediated by the Fas/FasL (CD95/APO1) signaling pathway.
    Ferreira CG; Tolis C; Span SW; Peters GJ; van Lopik T; Kummer AJ; Pinedo HM; Giaccone G
    Clin Cancer Res; 2000 Jan; 6(1):203-12. PubMed ID: 10656451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of caspases inhibits the release of apoptotic bodies: Bcl-2 inhibits the initiation of formation of apoptotic bodies in chemotherapeutic agent-induced apoptosis.
    Zhang J; Reedy MC; Hannun YA; Obeid LM
    J Cell Biol; 1999 Apr; 145(1):99-108. PubMed ID: 10189371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
    Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
    Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective induction of apoptosis in Hep 3B cells by topoisomerase I inhibitors: evidence for a protease-dependent pathway that does not activate cysteine protease P32.
    Adjei PN; Kaufmann SH; Leung WY; Mao F; Gores GJ
    J Clin Invest; 1996 Dec; 98(11):2588-96. PubMed ID: 8958222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas.
    Faubion WA; Guicciardi ME; Miyoshi H; Bronk SF; Roberts PJ; Svingen PA; Kaufmann SH; Gores GJ
    J Clin Invest; 1999 Jan; 103(1):137-45. PubMed ID: 9884343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ligation of CD40 potentiates Fas-mediated activation of the cysteine protease CPP32, cleavage of its death substrate PARP, and apoptosis in Ramos-Burkitt lymphoma B cells.
    An S; Yap D; Knox KA
    Cell Immunol; 1997 Nov; 181(2):139-52. PubMed ID: 9398401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ex vivo pediatric brain tumors express Fas (CD95) and FasL (CD95L) and are resistant to apoptosis induction.
    Riffkin CD; Gray AZ; Hawkins CJ; Chow CW; Ashley DM
    Neuro Oncol; 2001 Oct; 3(4):229-40. PubMed ID: 11584892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Common regulation of apoptosis signaling induced by CD95 and the DNA-damaging stimuli etoposide and gamma-radiation downstream from caspase-8 activation.
    Boesen-de Cock JG; Tepper AD; de Vries E; van Blitterswijk WJ; Borst J
    J Biol Chem; 1999 May; 274(20):14255-61. PubMed ID: 10318846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of the Fas pathway independently of Fas ligand during apoptosis induced by camptothecin in p53 mutant human colon carcinoma cells.
    Shao RG; Cao CX; Nieves-Neira W; Dimanche-Boitrel MT; Solary E; Pommier Y
    Oncogene; 2001 Apr; 20(15):1852-9. PubMed ID: 11313933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p21WAF1 prevents down-modulation of the apoptotic inhibitor protein c-IAP1 and inhibits leukemic apoptosis.
    Steinman RA; Johnson DE
    Mol Med; 2000 Sep; 6(9):736-49. PubMed ID: 11071269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progressive resistance to apoptosis in a cell lineage model of human proliferative breast disease.
    Starcevic SL; Elferink C; Novak RF
    J Natl Cancer Inst; 2001 May; 93(10):776-82. PubMed ID: 11353788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antileukemic drugs increase death receptor 5 levels and enhance Apo-2L-induced apoptosis of human acute leukemia cells.
    Wen J; Ramadevi N; Nguyen D; Perkins C; Worthington E; Bhalla K
    Blood; 2000 Dec; 96(12):3900-6. PubMed ID: 11090076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.